source
- Dr Chari on Frontline Combinations and Transplant Approaches in Multiple MyelomaAjai Chari, MD, discusses frontline treatment and transplant considerations in multiple myeloma.onclive · 2mo ago↗ source
- FDA Accepts sNDA for Taletrectinib in ROS1+ NSCLCAn sNDA with updated data for taletrectinib was accepted by the FDA for TKI-naive and pretreated advanced ROS1+ NSCLConclive · 2mo ago↗ source
- STAT+: Administration report on most favored nation drug pricing raises new details — and questionsAdministration report on most-favored nation drug pricing raises new details — and questions.STAT · 2mo ago↗ source